VCS And maxIT Healthcare Ranked In Top Ten For 2012 Best In KLAS Awards: Software & Services Report Companies Also Ranked in Categories Including ICD-10 Consulting, Clinical Implementation Principal, and Planning and Assessment
MCLEAN, Va., Feb. 11, 2013 /PRNewswire/ -- Vitalize Consulting Solutions (VCS) and maxIT Healthcare, wholly owned subsidiaries of Science Applications International Corporation (SAIC) (NYSE: SAI), announced they have achieved top ten rankings on the 2012 Best in KLAS Awards: Software & Services report (©2012 KLAS Enterprises, LLC. All rights reserved). VCS and maxIT ranked fourth and seventh in the Overall Services Firms category, respectively. KLAS publishes the annual report to help improve service delivery, by independently measuring vendor performance for the benefit of healthcare provider partners, consultants, investors, and vendors.
In addition to the Overall Services Firms ranking, maxIT Healthcare made the list for the new category ICD-10 Consulting, ranking fourth out of only six companies that qualified with KLAS Konfidence. Both VCS and maxIT Healthcare ranked highly in the Clinical Implementation Principal and the Planning and Assessment Category. Both firms meet this benchmark by offering services in areas including clinical implementation support services, planning and assessment, and staff augmentation.
The rankings follow SAIC's recent acquisition of maxIT Healthcare, which strengthened SAIC's capabilities to provide electronic health record (EHR) implementation and integration services to its commercial healthcare customers across North America, as well as its strong base of Federal healthcare customers as they move toward the use of commercial off the shelf (COTS) EHR applications. Together with VCS and maxIT Healthcare, SAIC is able to leverage its expertise in systems integration, life sciences and advanced data analytics to assist providers as they begin to personalize and deliver value-based healthcare.
"The Best in KLAS report is an excellent benchmark for the industry, and we are pleased that our customers have rated us highly once again," said Steve Comber, SAIC Health Solutions Business Unit general manager. "We will use the data in the report to work with our customers even more going forward to ensure the solutions and services we provide are helping them achieve their goals of improving patient care and reducing costs."
KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. For more information about KLAS, visit www.KLASresearch.com.
SAIC is a FORTUNE 500® scientific, engineering, and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. The Company's approximately 40,000 employees serve customers in the U.S. Department of Defense, the intelligence community, the U.S. Department of Homeland Security, other U.S. Government civil agencies and selected commercial markets. Headquartered in McLean, Va., SAIC had annual revenues of approximately $10.6 billion for its fiscal year ended January 31, 2012. For more information, visit http://www.saic.com/. SAIC: From Science to Solutions®
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in SAIC's Annual Report on Form 10-K for the period ended January 31, 2012, and other such filings that SAIC makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.